Life Sciences/HealthcareMergers & Acquisitions17.09.2024 News
Expansion in life sciences: Franziska Katterbach new partner at Oppenhoff
Oppenhoff has appointed Franziska Katterbach as a new partner in its Life Sciences / M&A department at the Frankfurt office as of 1 October 2024. Previously, she built up the European business as Managing Director at Khiron Life Sciences, a manufacturer and distributor of medical cannabis and operator of clinics.
Franziska Katterbach has many years of experience in the life sciences sector and in the cannabis industry in particular. Following her law studies, she began her career at Dentons, where she provided legal advice on international transactions, particularly in the life sciences sector. In 2018, Franziska Katterbach joined Canopy Growth Corporation as Director of Legal, Europe, before joining Khiron Life Sciences in 2019. At both companies, she navigated the European business through the highly regulated narcotics sector.
Myriam Baars-Schilling, the law firm’s chairwoman, stated: "We are delighted to have Franziska Katterbach strengthen our life sciences business with her high-calibre expertise. Her professional competence and in-depth industry knowledge are extremely valuable for our customised client work in this important future-oriented sector."
Franziska Katterbach stated: "I am delighted to be joining the Oppenhoff team and to be able to contribute my international expertise to the client work with important players in the life sciences and pharmaceutical industry."
Oppenhoff’s Healthcare sector group advises leading international pharmaceutical manufacturers, medical device manufacturers, biotech companies, hospitals, nursing homes, health insurance companies and service providers on day-to-day business, M&A transactions, regulatory issues, competition law and the German Medical Products Advertising Act and on securing industrial property rights. Together with clients, new solutions and business models are constantly being developed, for example for the digitisation of medical products, the cultivation of medical cannabis in Germany or development cooperations with start-ups.
Most recently, Oppenhoff was able to recruit Dr. Regina Engelstädter and Dr. Barnim von den Steinen for its corporate practice in Frankfurt.